BioCentury
ARTICLE | Company News

Elan, Sanders Morris Harris deal

January 26, 2004 8:00 AM UTC

ELN is selling its manufacturing and R&D business, Elan Pharma S.A. (Mezzovico, Switzerland), to affiliates of investment bank Sanders Morris Harris. The sale includes the associated fast-melt and eff...